High serum procalcitonin concentrations in patients with sepsis and infection

M Assicot, D Gendrel, H Carsin, J Raymond, J Guilbaud, C Bohuon, M Assicot, D Gendrel, H Carsin, J Raymond, J Guilbaud, C Bohuon

Abstract

High concentrations of calcitonin-like immunoreactivity have been found in the blood of patients with various extrathyroid diseases. By means of a monoclonal immunoradiometric assay for calcitonin precursors, we have measured serum concentrations of procalcitonin in patients with various bacterial and viral infections. 79 children (newborn to age 12 years) in hospital with suspected infections were investigated prospectively. 19 patients with severe bacterial infections had very high serum concentrations of procalcitonin at diagnosis (range 6-53 ng/mL) in comparison with 21 children found to have no signs of infection (baseline concentrations < 0.1 ng/mL). Serum procalcitonin values decreased rapidly during antibiotic therapy. 11 patients with peripheral bacterial colonisation or local infections without invasive sepsis and 18 (86%) of 21 patients with viral infections had concentrations within or slightly above the normal range (0.1-1.5 ng/mL). Among 9 severely burned patients studied in an intensive care unit, the post-traumatic course of procalcitonin concentrations (range 0.1-120 ng/mL) was closely related to infectious complications and acute septic episodes. Concentrations of mature calcitonin were normal in all subjects, whatever procalcitonin concentrations were found. Concentrations of a substance immunologically identical to procalcitonin are raised during septic conditions. Serum concentrations seem to be correlated with the severity of microbial invasion.

References

    1. Coombes Rc, Hillyard C., Greenberg Pb, MacIntyre I. Plasma immunoreactive-calcitonin in patients with non-thyroid tumours. Lancet. 1974;1:1080–1083.
    1. Milhaud G., Calmette C., Taboulet Jj, Julienne A., Moukhtar M. Hypersecretion of calcitonin in neoplastic conditions. Lancet. 1974;i:462–463.
    1. Becker Kl, Nash Dr, Silva Ol. Increased serum and urinary calcitonin levels in patients with pulmonary disease. Chest. 1981;79:211–216.
    1. Canale Dd, Donabedian Rk. Hypercalcitoninemia in acute pancreatitis. J Clin Endocrinol Metab. 1975;40:738–740.
    1. Gillquist J., Larsson J., Sjodahl R. Serum calcitonin in acute pancreatitis in man. Scand J Gastroenterol. 1977;12:21–23.
    1. Silva O., Becker Kl, Shalhoub Rj, Snider Rh, Bivins Le, Moore Cf. Calcitonin levels in chronic renal disease. Nephron. 1977;19:12–18.
    1. Fauchald P., Gautvik Vt, Gautvik Km. Immunoreactive parathyroid-hormone and calcitonin in plasma and ultrafiltrate before and after haemodialysis. Scand J Clin Lab Invest. 1985;45:229–235.
    1. Ghillani P., Motte P., Troalen F. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res. 1989;49:6845–6851.
    1. Mallet E., Lanse X., Devaux Am. Hypercalcitoninaemia in fulminant meningococcaemia in children. Lancet. 1983;1:294.
    1. Heath H., Sizemore Gw, Larson Jm, Jerpback Cm. Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent and peripheral blood of patients with medullary thyroid carcinoma. J Lab Clin Med. 1979;93:390–394.
    1. Deftos Lj, Ross Ba, Bronzert D., Pathermore Jg. Immunochemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab. 1975;40:409–412.
    1. Roos Ba, Huber Mb, Brinbaum Bs. Medullary thyroid carcinoma secretes a non-calcitonin peptide corresponding to the carboxyl terminal region of preprocalcitonin. J Clin Endocrinol Metab. 1983;56:802–807.
    1. Born W., Beglinger C., Fischer Ja. Diagnostic relevance of the amino-terminal cleavage peptide of procalcitonin (PAS-57), calcitonin and calcitonin gene-related peptide in medullary thyroid carcinoma patients. Regul Pep. 1991;32:311–319.
    1. Colon Jm, Grimelius L., Thim L. Structural characterization of a high-molecular-mass form of calcitonin [procalcitonin-(60-116) -peptide] and its corresponding N-terminal flanking peptide [procalcitonin-(1-57)-peptide] in a human medullary thyroid carcinoma. Biochemistry. 1988;256:245–250.
    1. Becker Kl, Monaghan Kg, Silva Ol. Immunocytochemical localization of calcitonin in Kultschitzky cells of human lung. Arch Pathol Lab Med. 1980;104:196–198.
    1. Minvielle S., Giscard-Dartevelle S., Cohen R. A novel calcitonin carboxy-terminal peptide produced in medullary thyroid carcinoma by alternative RNA processing of the calcitonin/calcitonin gene-related peptide gene. J Biol Chem. 1991;36:24627–24631.
    1. Joyce Cd, Fiscus Rr, Wang X. Calcitonin gene-related peptide levels are elevated in patients with sepsis. Surgery. 1990;108:1097–1101.

Source: PubMed

3
購読する